STAT: 48 hours; Routine: 5 days
HLA Antibody Specificity Class II
HLA Antibody Specificity Class I
Donor Specific Ab Testing
Donor Specific Antibody (DSA)
Class I & II SAB Antibody Screening
Looking to order a test?
We’ve provided helpful links to make ordering easy.Find a Requisition
All specimens should be accompanied by a requisition.Submitting Specimens
Learn about how to properly label and where to ship specimens.Order Kits and Supplies
MLabs provides all the supplies necessary for the collection of specimens.Test FAQ
Visit our provider FAQ and learn about common questions to ordering tests.
Solid Phase Antibody Screening
The antibodies directed to the possible donor or an already transplanted organ are known as Donor Specific Antibodies (DSA). These DSA are associated with an increased risk of graft loss and/or rejection. The damage produced by the recognition of the HLA antigens on the surface of the graft endothelium by the DSA result in the rejection process known as Antibody Mediated Rejection (AMR).
The high specificity and sensitivity of the current solid phase single antigen assay allow us the detection of low-level of the precise DSA. The detection of DSA in pre-transplant evaluation is an excellent tool for risk assessment and crossmatch prediction (Virtual Crossmatch and CPRA). The routine monitoring of DSA in the post-transplant setting assist the transplant team in the characterization of the rejection process and the treatment decisions.
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.